Ignite Creation Date:
2024-05-06 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04708418
Status:
SUSPENDED
Last Update Posted:
2024-07-03
First Post:
2021-01-13
Brief Title:
A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy in Patients With Operable Melanoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Cutaneous Melanoma |
| Clinical Stage III Cutaneous Melanoma AJCC v8 |
| Melanoma of Unknown Primary |
| Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 |
| Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 |
| Pathologic Stage IIID Cutaneous Melanoma AJCC v8 |
Keywords: